We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AYTU (MC $16 M) (Cash $11.8 M) 4 Marketed Products +Big Drug
AYTU 3.310-0.9%Jan 27 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BioHero10/13/2017 3:23:55 PM
   of 20
Lots of product launches expected in the coming weeks and months which means much much higher revenue .This lextreme low float stock is definitely terrible underpriced at this price and with Nasdaq listing in sight this stock will attract more institutional investors and with such low float this stock will explode to upside .GL


The 10 largest shareholders alone owned almost half of the outstanding shares of 4.2 million which is very strong .

Armistice Capital LLC 405 641
Manchester Management Co. LLC 210 331
JEB Partners LP 200 000
Aigh Partners LP 181 500
Galileo Partners LLC 150 000
JMG Capital Management LLC 116 665
Joshua R. Disbrow, MBA 114 843
Jarrett T. Disbrow, PhD 113 384
Lincoln Park Capital Fund LLC 100 000

Triple Gate Capital GP LLC 100 000

Aytu BioScience Announces International Distribution Agreement for Fiera® in Japan

Aytu BioScience Expands MiOXSYS® Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext